Substrate-selective co-fermentation process
US-9212346-B2 · Dec 15, 2015 · US
US10066246B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10066246-B2 |
| Application number | US-201314416631-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 25, 2013 |
| Priority date | Jul 25, 2012 |
| Publication date | Sep 4, 2018 |
| Grant date | Sep 4, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Recombinant yeast cells contain a reductive TCA pathway from phosphoenolpyruvate or pyruvate to succinate. At least one metabolic step in the pathway includes a reaction of NADPH to produce NADP+. The yeast cell contains at least one exogenous NADPH-dependent gene in the pathway from phosphoenolpyruvate or pyruvate to succinate, preferably an NADPH-dependent malate dehydrogensase or fumarate reducase gene (or both).
Opening claim text (preview).
The invention claimed is: 1. A recombinant I. orientalis cell having an active reductive TCA pathway from pyruvate to succinate and which further metabolizes succinate to one or more succinate metabolization products, which reductive TCA pathway includes a reaction that oxidizes NADPH to NADP+ comprising a conversion of fumarate to succinate catalyzed by an NADPH-dependent fumarate reductase enzyme and the recombinant cell has integrated into its genome an heterologous fumarate reductase gene that encodes for the NADPH-dependent fumarate reductase enzyme. 2. The recombinant cell of claim 1 , wherein the recombinant cell further includes a reaction that oxidizes NADPH to NADP+comprising a conversion of oxaloacetate to malate catalyzed by an NADPH-dependent malate dehydrogenase enzyme and the recombinant cell has integrated into its genome an heterologous malate dehydrogenase gene that encodes for the NADPH-dependent malate dehydrogenase enzyme. 3. The recombinant cell of claim 1 wherein the recombinant cell further includes a step of converting pyruvate or phosphoenolpyruvate to oxaloacetate, a step of converting oxaloacetate to malate, and a step of converting malate to fumarate. 4. The recombinant I. orientalis cell of claim 1 , wherein the succinate metabolization product is one or more of 1,4-butanediol, 1,3-butadiene, propionic acid, and 3-hydroxyisobutryic acid.
from Saccharomyces · CPC title
Dicarboxylic acids having four or less carbon atoms, e.g. fumaric acid, maleic acid · CPC title
Lyases (4.) · CPC title
Pyruvate carboxylase (6.4.1.1) · CPC title
acting on CH-OH groups as donors (1.1) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.